Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.64 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.64 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.52 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | HTR6 | P50406 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12852124 | 0.91 | MEN1 (0.61) | MEN1KMT2ATNNI3TNNT2TNNC1 | |
| SCHEMBL5049991 | 0.84 | KDM4E (0.61) | MEN1KMT2ATNNI3TNNT2TNNC1 | |
| SCHEMBL15158394 | 0.79 | MAPT (0.51) | MEN1KMT2ATNNI3TNNT2TNNC1 | |
| SCHEMBL2519816 | 0.79 | MEN1 (1.00) | MEN1KMT2ATNNI3TNNT2TNNC1 | |
| SCHEMBL1720604 | 0.76 | MAPT (0.64) | MEN1KMT2ATNNI3TNNT2TNNC1 | |
| SCHEMBL12293604 | 0.76 | ALDH1A1 (0.55) | MEN1KMT2ATNNI3TNNT2TNNC1 | |
| SCHEMBL10063866 | 0.75 | KMT2A (0.60) | MEN1KMT2ATNNI3TNNT2TNNC1 | |
| SCHEMBL14890983 | 0.74 | ALDH1A1 (0.42) | MEN1KMT2ATNNI3TNNT2TNNC1 | |
| SCHEMBL9138641 | 0.74 | KDM4E (0.66) | MEN1KMT2ATNNI3TNNT2TNNC1 | |
| 2-Methyl Gramine SCHEMBL2519973 | 0.74 | MAPT (1.00) | MEN1KMT2AMAPTCYP3A4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070479-A | Ultrasonic indicating device and method for monitoring ultrasonic treatment | JP实验室股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| WO-2025090061-A1 | ULTRASONIC INDICATOR DEVICE AND METHOD FOR MONITORING ULTRASONICATION | JP LABORATORIES, INC. (US) | 2025-05-01 | — | — | WO | claimed |
| WO-2025075611-A1 | ULTRASONIC INDICATOR BASED ON EMULSION FORMATION | JP LABORATORIES, INC. (US) | 2025-04-10 | — | — | WO | claimed |
| US-12637489-B2 | Silicon containing modified nucleotide analogs | Singular Genomics Systems, Inc. (US) | 2026-05-26 | — | — | US | disclosed |
| CN-122070479-A | Ultrasonic indicating device and method for monitoring ultrasonic treatment | JP实验室股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| US-12630808-B2 | Modified archaeal family b polymerases | Singular Genomics Systems, Inc. (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260125660-A1 | MODIFIED ARCHAEAL FAMILY B POLYMERASES | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260110028-A1 | NUCLEOTIDE ANALOGS AND USES THEREOF | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-12595508-B2 | Nucleotide cleavable linkers and uses thereof | Singular Genomics Systems, Inc. (US) | 2026-04-07 | — | — | US | disclosed |
| US-20260085299-A1 | ENGINEERED PYROCOCCUS ENZYMES AND USES THEREOF | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-03-26 | — | — | US | disclosed |
| US-12577271-B2 | Modified nucleotides and uses thereof | Singular Genomics Systems, Inc. (US) | 2026-03-17 | — | — | US | disclosed |
| WO-2022072374-A1 | LIGHT-CONTROLLED BIOORTHOGONAL TETRAZINE LIGATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-04-07 | — | — | WO | disclosed |
| US-11266673-B2 | Nucleotide derivatives and methods of use thereof | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2022-03-08 | — | — | US | disclosed |
| US-8765894-B2 | Norbornene-type polymers having quaternary ammonium functionality | PROMERUS, LLC (US) | 2014-07-01 | — | — | US | disclosed |
| US-8765893-B2 | Norbornene-type polymers having quaternary ammonium functionality | PROMERUS, LLC (US) | 2014-07-01 | — | — | US | disclosed |
| US-20110244368-A1 | NORBORNENE-TYPE POLYMERS HAVING QUATERNARY AMMONIUM FUNCTIONALITY | PROMERUS LLC (US) | 2011-10-06 | — | — | US | disclosed |
| US-20110143260-A1 | NORBORNENE-TYPE POLYMERS HAVING QUATERNARY AMMONIUM FUNCTIONALITY | PROMERUS LLC (US) | 2011-06-16 | — | — | US | disclosed |
| US-20100260903-A1 | DEVICE FOR THE QUALIFICATION OF COOKING OILS, AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY | 2010-10-14 | — | — | US | disclosed |
| EP-2104854-A1 | DEVICE FOR THE QUALIFICATION OF COOKING OILS, AND METHODS | 3M Innovative Properties Company (US) | 2009-09-30 | — | — | EP | disclosed |
| WO-2008086137-A1 | DEVICE FOR THE QUALIFICATION OF COOKING OILS, AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630808-B2 | Modified archaeal family b polymerases | SSU72, POLB, POLQ | MEN1 3513/4885KMT2A 308/4885TNNI3 3698/4885 |
| US-12595508-B2 | Nucleotide cleavable linkers and uses thereof | NSUN2, CCRL2, NOP2 | MEN1 4378/4885KMT2A 2804/4885TNNI3 84/4885 |
| US-12577271-B2 | Modified nucleotides and uses thereof | NUDT1, NSUN2, CCRL2 | MEN1 2476/4885KMT2A 2809/4885TNNI3 496/4885 |
| US-12637489-B2 | Silicon containing modified nucleotide analogs | NSUN2, POLR2H, POLH | MEN1 2394/4885KMT2A 2375/4885TNNI3 434/4885 |
| US-20260110028-A1 | NUCLEOTIDE ANALOGS AND USES THEREOF | POLL, POLB, POLN | MEN1 3638/4885KMT2A 1209/4885TNNI3 2537/4885 |
| US-20260085299-A1 | ENGINEERED PYROCOCCUS ENZYMES AND USES THEREOF | POLB, POLM, POLRMT | MEN1 1571/4885KMT2A 1696/4885TNNI3 3769/4885 |
| US-20260125660-A1 | MODIFIED ARCHAEAL FAMILY B POLYMERASES | DNMT3A, POLB, POLM | MEN1 2077/4885KMT2A 755/4885TNNI3 4481/4885 |
| US-11266673-B2 | Nucleotide derivatives and methods of use thereof | POLRMT, NSUN2, NUDT1 | MEN1 3223/4885KMT2A 1863/4885TNNI3 910/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.